Check Before You Invest : Onyx Biotec Ltd

Snapshot

Q.1 Which industry/sub-sector does Onyx Biotec Ltd belong to?

Onyx Biotec Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Onyx Biotec Ltd a good quality company?

Onyx Biotec Ltd is a quality company, based on a 4-year financial track record.

Q.3 Is Onyx Biotec Ltd undervalued or overvalued?

Onyx Biotec Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.

Q.4 Is Onyx Biotec Ltd a good buy now?

Onyx Biotec Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Onyx Biotec Ltd?

Onyx Biotec Ltd revenue growth is 15.3% for FY-2025, which is above its 3-year CAGR of 11.36%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Onyx Biotec Ltd?

Onyx Biotec Ltd Return on capital employed is 13.68% for FY-2025, which is above its 3-year historical median of 12.85%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Onyx Biotec Ltd?

Onyx Biotec Ltd Return on Asset is 5.99%, which is above its 3-year historical median of 5.47%, indicating improved asset utilization efficiency.

Q.4 Return on Equity (ROE) of Onyx Biotec Ltd?

Onyx Biotec Ltd Return on equity is 12.25% for FY-2025, which is in line with its 3-year historical median of 12.25%, indicating the business is making similar use of its shareholders capital.

Q.5 Cash conversion cycle of Onyx Biotec Ltd?

Onyx Biotec Ltd Cash conversion cycle is 74 days, above its 3-year historical median of 49 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	3-year Historic Median
Asset Turnover	0.75	0.81
ROE	12.25	12.25
ROCE	13.68	12.85
Cash Conversion Cycle	74 days	49 days

Q.6 Gross Profit margin of Onyx Biotec Ltd?

Onyx Biotec Ltd Gross profit margin which is the profit after deduction of direct costs, is 15.4% for FY-2025, which is above its 3-year median of 11.8%, indicating increasing margins.

Q.7 Operating Profit Margin of Onyx Biotec Ltd?

Onyx Biotec Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 16.74% for FY-2025, which is above its 3-year median of 15.61% indicating increasing margins.

Q.8 Net Profit Margin of Onyx Biotec Ltd?

Onyx Biotec Ltd Net Profit Margin is 8% for FY-2025, is above with its 3-year median of 6.76%, indicating increasing margins.

	Current Level	3-year Historic Median
Gross Profit Margin	15.4	11.8
Operating Profit Margin	16.74	15.61
Net Profit Margin	8	6.76

Q.9 Debt to Equity ratio of Onyx Biotec Ltd?

Onyx Biotec Ltd Debt-to-Equity ratio is 0.22, which is lower with the industry average of 0.25, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Onyx Biotec Ltd?

Onyx Biotec Ltd Debt to cash flow from operations is 8.79, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Onyx Biotec Ltd?

Promoters hold 65.10% of the Onyx Biotec Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Onyx Biotec Ltd vs industry peers?

Onyx Biotec Ltd revenue CAGR is 11.36%, compared to the industry median CAGR of 8.24%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	3-year Industry Median
Revenue Growth	15.3	8.2
Gross Profit Growth	49.8	11.2
Operating Profit Growth	23.6	9.8
Net Profit Growth	36.4	8.1

Operating Efficiency

	Current Level	3-year Industry Median
Asset Turnover	0.75	0.78
ROE	12.25	9.5
ROCE	13.68	11.4
Cash Conversion Cycle (days)	73.94	83

Valuation & price assessment

Q.1 Stock return of Onyx Biotec Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of -40.54% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-	-	-40.5%

Q.3 Valuation ratios of Onyx Biotec Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 3-year historical median and industry numbers?

Valuation Ratios	Current	3-year Historic Median	3-year Industry Median
Price to Earnings	12.08	17.78	33.44
Price to Book	1.08	1.79	3.09
Price to Sales	0.97	1.42	3.40
EV to EBITDA	5.52	10.20	16.10

Check more companies

6. Wockhardt

7. Pfizer

8. Piramal Pharma

9. Acutaas Chemicals

10. Astrazeneca Pharma I

Check trending companies

1. Info Edge (India) Ltd.

2. Tata Motors Passenger Vehicles Ltd.

3. Bajaj Finserv Ltd.

4. Ultratech Cement Ltd.

5. Titan Company Ltd.